Literature DB >> 24958838

Medicinal cannabis: time to lighten up?

David N Juurlink1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24958838      PMCID： PMC4150698          DOI： 10.1503/cmaj.140309

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Facing up to the prescription opioid crisis.

Authors:  Irfan A Dhalla; Navindra Persaud; David N Juurlink
Journal:  BMJ       Date:  2011-08-23

Review 2.  Dependence and addiction during chronic opioid therapy.

Authors:  David N Juurlink; Irfan A Dhalla
Journal:  J Med Toxicol       Date:  2012-12

Review 3.  Marijuana and lung diseases.

Authors:  Manish Joshi; Anita Joshi; Thaddeus Bartter
Journal:  Curr Opin Pulm Med       Date:  2014-03       Impact factor: 3.155

Review 4.  Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

Authors:  Mary E Lynch; Fiona Campbell
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

5.  Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs.

Authors:  Muhammad Mamdani; Paula A Rochon; David N Juurlink; Alex Kopp; Geoffrey M Anderson; Gary Naglie; Peter C Austin; Andreas Laupacis
Journal:  BMJ       Date:  2002-09-21

Review 6.  Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.

Authors:  Roger Chou; Jane C Ballantyne; Gilbert J Fanciullo; Perry G Fine; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

Review 7.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

8.  Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.

Authors:  Muhammad Mamdani; David N Juurlink; Douglas S Lee; Paula A Rochon; Alex Kopp; Gary Naglie; Peter C Austin; Andreas Laupacis; Therese A Stukel
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

Review 9.  Cannabis and schizophrenia.

Authors:  John Rathbone; Hannele Variend; Hetal Mehta
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

10.  Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?

Authors:  Igor Kissin
Journal:  J Pain Res       Date:  2013-07-04       Impact factor: 3.133
  10 in total
  3 in total

1.  Cannabis and Mental Health: Insights from Canadian Research.

Authors:  Rebecca Haines-Saah
Journal:  Can J Psychiatry       Date:  2019-05       Impact factor: 4.356

2.  Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec.

Authors:  Huguette St-Amant; Mark A Ware; Nancy Julien; Anaïs Lacasse
Journal:  CMAJ Open       Date:  2015-04-02

3.  Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians.

Authors:  Richard James Huntsman; Richard Tang-Wai; Bryan Acton; Jane Alcorn; Andrew William Lyon; Darrell David Mousseau; Blair Seifert; Robert Laprairie; Erin Prosser-Loose; Lumir Ondrej Hanuš
Journal:  Paediatr Child Health       Date:  2018-04-05       Impact factor: 2.253
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.